Patients Coming Off Anti-Obesity Medications Put On Pounds at a Quadrupled Rate Than Dieters

New research reveals that patients who discontinue new weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who stop traditional lifestyle plans.

Findings released in a prominent medical journal demonstrates that while obese individuals can lose about a fifth of their total mass while on the medication, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"Users purchasing these medications need to be cognizant of the risk of rapid rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.

This pace of recovery means a return to original weight in about a year and a half.

Comparing Approaches

The study, which looked at 37 of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.

Researchers emphasize that people who shed pounds through diet and exercise generally experience a slower creep back—around 100 grams monthly—after stopping.

Explaining the Fast Rebound

Nutrition scientists believe the mechanism of the drugs accounts for the heightened weight return.

These medications mimic a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication means appetite is uncontrolled, making excessive eating far more likely."

A Lifelong Condition?

The NHS advise the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Professionals say that, considering the high risk of weight regain, the therapy should be considered ongoing.

This opinion is supported by pharmaceutical companies, who state that the results "highlight the chronic character of obesity," comparing it to managing diseases like hypertension.

User Testimonies

Users who have discontinued the medication report a intense resurgence of hunger.

"I experienced something activating and you're instantly extremely hungry," said one woman.

The struggle is exacerbated if individuals have not established permanent lifestyle or habit changes during therapy.

Significant Interest

Survey data indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with demand remaining high.

• Use is higher among females than males.
• The middle-aged demographic shows the highest level of interest.
• Many obtain the drugs through private prescriptions rather than the NHS.

In conclusion, researchers emphasize that while these medications are effective agents for shedding pounds, they are not a permanent fix and maintained weight loss relies on combined behavioural changes.